Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 9, 2008

Premium
Lewis Rumpler has joined Signature Genomic Laboratories as vice president of business development.
 
Rumpler previously served as chief operating officer of the Institute for Systems Medicine Planning Authority, a non-profit organization dedicated to developing the Institute for Systems Medicine, a biomedical research institute. He was also CEO of Pacific Northwest Biotechnology
 
Rumpler holds a BS in cellular and molecular biology and a BA in zoology from the University of Washington.
 

 
BioNanomatrix has named Gary Zweiger as vice president of business development. Zweiger formerly was senior director of business development at Affymetrix, and he has served in the same position for Applied Biosystems’ Cell and Molecular Biology division. He also worked in business development at Agilent Technologies, and he performed a fellowship at Genentech
 

 
Ronald Lowy has taken over as CEO at Helicos BioSciences for Steve Lombardi, who will stay on in his roles as president of the company and member of the board of directors. Lowy has served on the board since November 2007, a post he will retain. He previously served as president and CEO of Fisher Biosciences, a division of Fisher Scientific, and held management positions at GE Medical Systems.
 
Lombardi will now focus his efforts on commercializing the company’s HeliScope system product line.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.